Consultancy Services

Dr. Declan King offers strategic advisory services for pharmaceutical, biotech, and academic partners. Leveraging 20+ years of research leadership, he provides specialized guidance on de-risking neurodegenerative pipelines through advanced biomarker integration and translational study design.

Engagements are tailored to project scope and specific development milestones.

Areas of Engagement:

Translational Biomarker Strategy

Strategic guidance on the selection and validation of synaptic biomarkers (such as SV2A PET) for Phase I/II neurodegeneration programs. I help sponsors establish objective evidence of target engagement.

Synaptic Resilience & Study Design

Advisory on the design and interpretation of studies investigating synaptic preservation. I provide expertise in bridging post-mortem molecular data with in-vivo imaging endpoints to de-risk drug development.

Scientific Advisory & Peer Review

High-level consultancy for research project planning, trial methodology, and publication strategy, leveraging 20+ years of academic and industry-facing research experience.

Ready to integrate advanced synaptic biomarkers into your next program? Contact Dr. Declan King to discuss your project requirements and receive a tailored technical proposal.

Professional Disclaimer Dr. Declan King provides strategic neuroscience consultancy and research advisory services only. All insights and deliverables are intended for informational and research purposes and do not constitute medical advice, diagnosis, or treatment. Engagement terms and investment are determined by project scope and technical complexity.